Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial

R. G. Langley; T. F. Tsai; S. Flavin; M. Song; B. Randazzo; Y. Wasfi; J. Jiang; S. Li; L. Puig

doi:10.1111/bjd.15750

Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial

R. G. Langley, T. F. Tsai, S. Flavin, M. Song, B. Randazzo, Y. Wasfi, J. Jiang, S. Li, L. Puig

Inernational Relations Division

Research output: Contribution to journal › Article › peer-review

283 Citations (Scopus)

Original language	English
Pages (from-to)	114-123
Number of pages	10
Journal	British Journal of Dermatology
Volume	178
Issue number	1
DOIs	https://doi.org/10.1111/bjd.15750
Publication status	Published - Jan 2018

ASJC Scopus Subject Areas

Dermatology

Access to Document

10.1111/bjd.15750

Cite this

Langley, R. G., Tsai, T. F., Flavin, S., Song, M., Randazzo, B., Wasfi, Y., Jiang, J., Li, S., & Puig, L. (2018). Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial. British Journal of Dermatology, 178(1), 114-123. https://doi.org/10.1111/bjd.15750

Langley, RG, Tsai, TF, Flavin, S, Song, M, Randazzo, B, Wasfi, Y, Jiang, J, Li, S & Puig, L 2018, 'Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial', British Journal of Dermatology, vol. 178, no. 1, pp. 114-123. https://doi.org/10.1111/bjd.15750

@article{d0acde31f775423381d4b8f64f4afa13,

title = "Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial",

author = "Langley, {R. G.} and Tsai, {T. F.} and S. Flavin and M. Song and B. Randazzo and Y. Wasfi and J. Jiang and S. Li and L. Puig",

note = "Funding Information: This study was funded by Janssen Research & Development, LLC. Employees of the sponsor were involved in study design, data collection, analysis and interpretation. All authors, including those who are employees of the study sponsor, drafted and/or revised the manuscript and approved the final version for submission. Publisher Copyright: {\textcopyright} 2017 British Association of Dermatologists",

year = "2018",

month = jan,

doi = "10.1111/bjd.15750",

language = "English",

volume = "178",

pages = "114--123",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab

T2 - results of the randomized, double-blind, phase III NAVIGATE trial

AU - Langley, R. G.

AU - Tsai, T. F.

AU - Flavin, S.

AU - Song, M.

AU - Randazzo, B.

AU - Wasfi, Y.

AU - Jiang, J.

AU - Li, S.

AU - Puig, L.

N1 - Funding Information: This study was funded by Janssen Research & Development, LLC. Employees of the sponsor were involved in study design, data collection, analysis and interpretation. All authors, including those who are employees of the study sponsor, drafted and/or revised the manuscript and approved the final version for submission. Publisher Copyright: © 2017 British Association of Dermatologists

PY - 2018/1

Y1 - 2018/1

UR - http://www.scopus.com/inward/record.url?scp=85028508389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028508389&partnerID=8YFLogxK

U2 - 10.1111/bjd.15750

DO - 10.1111/bjd.15750

M3 - Article

C2 - 28635018

AN - SCOPUS:85028508389

SN - 0007-0963

VL - 178

SP - 114

EP - 123

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 1

ER -

Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this